Guangzhou Baiy | 600332 - Gross Profit On Sales

Stock Price
25.61
Daily Change
0.06 0.23%
Monthly
0.67%
Yearly
-5.60%
Q1 Forecast
24.69

Guangzhou Baiy reported CNY3.2B in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Aspen Pharmacare ZAR 10.14B 830M Jun/2024
Cipla INR 41.64B 6.31B Dec/2025
Dr.Reddys Laboratories INR 51.37B 629M Dec/2025
Jiangsu Hengrui CNY 6.36B 1.15B Sep/2025
Kalbe Farma IDR 3.45T 151.13B Sep/2025
Richter Gedeon HUF 143.37B 4.3B Sep/2025
Sh Fosun Pharma CNY 4.8B 93.72M Sep/2025
Sh Pharmaceutical CNY 7.45B 223.01M Sep/2025
Sun Pharmaceuticals INR 107.66B 2.05B Sep/2025
Teva Pharmaceutical Industries USD 2.66B 351M Dec/2025